Roman Yelensky

Molecular Biology · 2003–2017

A researcher in the Science corpus: 8 papers; trusts 6 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 73 citations into it
• Genetics — 58 citations into it; #3,353 of 6,854 by trust here, #1,889 by citations

Whom Roman Yelensky trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Timothy L. Bailey
2. Arthur P. Dempster
3. Harmen J. Bussemaker
4. Michael Olivier

Who trusts Roman Yelensky overall

1. Jonathan Marchini
2. Evangelos Evangelou
3. G. Di Leo

Papers from Roman Yelensky's perspective

Ordered by how strongly the researchers Roman Yelensky trusts endorse each paper. Same corpus, a different order for every researcher.

1. High-resolution haplotype structure in the human genome (Nature Genetics)
2. BioProspector: Discovering Conserved DNA Motifs in Upstream Regulatory Regions of Co-Expressed Genes (Pacific Symposium on Biocomputing)
3. Functional organization of the yeast proteome by systematic analysis of protein complexes (Nature)
4. The cancer genome (Nature)
5. Fitting a Mixture Model By Expectation Maximization To Discover Motifs In Biopolymer
6. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. (American Journal of Human Genetics)
7. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper
8. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry (Nature)
9. Blocks of Limited Haplotype Diversity Revealed by High-Resolution Scanning of Human Chromosome 21 (Science)
10. Calibrating a coalescent simulation of human genome sequence variation. (Genome Research)

Their papers

• Genome-wide discovery of transcriptional modules from DNA sequence and gene expression (2003) — 303 citations
• Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing (2013) — 2,044 citations
• Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. (2017) — 1,057 citations
• Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. (2015) — 714 citations
• Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor positive breast cancer (2014) — 595 citations
• Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies (2012) — 867 citations
• Estimation of the multiple testing burden for genomewide association studies of nearly all common variants (2008) — 844 citations
• Efficiency and power in genetic association studies (2005) — 1,821 citations